A 32-year-old male current smoker (20 pack-year history) presents with progressive dyspnea, dry cough, and a second spontaneous left pneumothorax. HRCT chest shows bizarre-shaped thin-walled cysts and centrilobular nodules in the upper and middle lobes with sparing of costophrenic angles. Lung biopsy confirms Langerhans cell histiocytosis with CD1a+ and Langerin+ cells. His pulmonary function tests show: FVC 78% predicted, FEV1 60% predicted, FEV1/FVC ratio 65%, TLC 95% predicted, RV 110% predicted, and DLCO 45% predicted. The pattern marked **B** in the diagram best represents his spirometric and diffusion findings. Which of the following mechanisms BEST explains the disproportionately reduced DLCO in this patient's PFT pattern?
A. Cystic destruction of distal airspaces and associated pulmonary vasculopathy reducing the alveolar-capillary interface
B. Hyperinflation-induced reduction in elastic recoil pressure across the alveolar-capillary membrane
C. Reversible small airway obstruction from bronchial inflammation without parenchymal destruction
D. Purely restrictive fibrosis with uniform loss of lung parenchyma and reduced alveolar surface area
Explanation
Why option 1 is correct
In pulmonary Langerhans cell histiocytosis (PLCH), the pathophysiology involves both cystic destruction of distal airspaces (producing obstructive features and gas trapping) and associated pulmonary vasculopathy. The combination of parenchymal cyst formation destroying the alveolar-capillary interface AND direct vasculopathy of the pulmonary vessels results in a disproportionately reduced DLCO relative to the degree of restriction or obstruction. This is the hallmark of the mixed obstructive/restrictive pattern with markedly reduced DLCO (45% predicted in this case) despite relatively preserved TLC (95% predicted). The BRAF V600E mutation drives MAP-kinase pathway activation, promoting both the Langerhans cell proliferation and the vascular remodeling that characterizes advanced PLCH (Vassallo et al., NEJM 2002; ATS/ERS Statement on Smoking-Related ILD).
Why each distractor is wrong
Option 2: Pure restrictive fibrosis would reduce both FVC and TLC proportionately and would not explain the obstructive component (reduced FEV1/FVC ratio of 65%) or the gas trapping (elevated RV of 110% predicted). PLCH is not a purely restrictive disease.
Option 3: Reversible small airway obstruction from bronchial inflammation alone does not explain the marked reduction in DLCO (45% predicted) or the parenchymal cyst formation seen on HRCT. The DLCO reduction in PLCH is due to structural parenchymal and vascular pathology, not reversible inflammation.
Option 4: Hyperinflation (elevated RV and normal TLC) is a consequence of cystic airspace destruction and gas trapping, not the primary mechanism of DLCO reduction. Elastic recoil pressure changes do not directly explain the disproportionate DLCO loss in the presence of relatively preserved lung volumes.
High-YieldNEET PG
PLCH is a smoking-related clonal neoplastic disorder (BRAF V600E+) with a characteristic mixed obstructive/restrictive PFT pattern and DISPROPORTIONATELY REDUCED DLCO due to cystic parenchymal destruction plus pulmonary vasculopathy; smoking cessation is the cornerstone of management.
Vassallo et al., NEJM 2002; ATS/ERS Statement on Smoking-Related ILD
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
